Abstract
Summary
The physiological behavior of trivalent and hexavalent Cr51 has been observed over a 4 5-day period in rats as affected by chemical form and route of administration. When intravenously administered as sodium chromite, practically 100% of the dose was picked up by the organs of the reticuloendothelial system. Chromic chloride resulted in a pickup by the liver of about 55% of the dose. When Cr51Cl3 was added to isotonic acetate and citrate buffers; less than 5% of the dose reached the liver and most of the activity was excreted in the urine. The use of sodium chromate solutions resulted in about 25% of the dose reaching the liver. However, the activity left this organ rapidly in contradistinction to the other forms studied. Oral, intraperitoneal and intratracheal administration of Cr51Cl3 were also studied. None of the forms of Cr51 used were found to cross the placenta of rats ranging from 15 to 20 days in gestation. In addition, data are presented from 2 sheep intravenously dosed with Cr51Cl3. The above physiological observations are correlated with the colloidal behavior, complex formation, protein binding, and red cell binding, and are in general agreement with interpretations of filter paper elec-trophoretic studies of the dosing solutions.
Get full access to this article
View all access options for this article.
